ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference
Rhea-AI Summary
ESSA Pharma (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for prostate cancer treatment, has announced its participation in the 2024 Cantor Global Healthcare Conference. The company will present on September 18, 2024, at 9:10 a.m. ET in New York, NY.
Key executives participating in a fireside chat include David R. Parkinson (President and CEO), Peter Virsik (COO and EVP), and David S. Wood (CFO). A live webcast of the event will be available on ESSA's website in the Investors/Events & Presentations section, and will remain archived for 90 days post-event.
Positive
- None.
Negative
- None.
News Market Reaction – EPIX
In the trading session that priced this news, EPIX gained 0.57%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
David R. Parkinson, President and Chief Executive Officer, Peter Virsik, Chief Operating Officer and Executive Vice President, and David S. Wood, Chief Financial Officer, will participate in a fireside chat.
A live webcast of the fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essaphrma.com, and follow us on X and LinkedIn.
Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-2024-cantor-global-healthcare-conference-302244410.html
SOURCE ESSA Pharma Inc